| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5159031 | European Journal of Medicinal Chemistry | 2017 | 34 Pages |
Abstract
Compound 8e which was designed based on anthranilamide derivative X007 displayed excellent in vivo and in vitro antithrombotic activity and could be considered as a potential fXa inhibitor for the prevention and treatment of thromboembolic diseases.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Junhao Xing, Lingyun Yang, Yifei Yang, Leilei Zhao, Qiangqiang Wei, Jian Zhang, Jinpei Zhou, Huibin Zhang,